Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG

NCT07226830 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis Generalized

Sponsor

BioSensics

Collaborators

[object Object]